Research Use Only - Not for human consumption. 18+ only.
BGrade BSmaller human trials, observational studies, or approved in 30+ countriesResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use onlyImmune & Inflammatory ModulationIntranasal

VIP

Also known as: Vasoactive Intestinal Peptide, Vasoactive Intestinal Polypeptide

VIP is a neuropeptide with wide-ranging effects including immune modulation, neuroprotection, and treatment of chronic inflammatory response syndrome (CIRS).

Beginner Basics

Plain-English guide to VIP

What it does

VIP is a natural signaling molecule that helps calm down an overactive immune system and reduce inflammation throughout the body. Researchers commonly use it to help people with chronic inflammatory conditions, including those related to mold exposure.

Typical dose

50 micrograms sprayed into the nose four times per day, spaced about 4-6 hours apart.

When to inject

Space doses evenly throughout the day (roughly every 4-6 hours), such as morning, midday, late afternoon, and evening. Timing flexibility is acceptable as long as doses don't bunch together.

Storage

Keep the dry powder in the refrigerator between 36-46°F (2-8°C) until you mix it. Once mixed with saline, store in the refrigerator and use within the timeframe your supplier recommends.

First-timer tip

Use a nasal spray bottle for consistency and to ensure the peptide reaches the nasal passages properly-this matters more than injecting since it's absorbed through the nose, not under the skin.

Research Status

BGrade BSmaller human trials, observational studies, or approved in 30+ countriesResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only

Research compound - used clinically for CIRS

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Modulates immune system
Reduces inflammation
Treats CIRS and mold illness
Neuroprotective effects
Improves pulmonary function
May help autoimmune conditions

Side Effects

Facial flushing
CommonMild

Transient vasodilation, typically occurs within minutes of injection and resolves within 15-30 minutes. More common with higher doses or rapid injection. Manage by slowing injection speed and allowing solution to warm to room temperature.

Headache
CommonMild

Mild to moderate headache may occur, particularly with intranasal administration. Usually self-resolving within 1-2 hours. Stay hydrated and rest in a quiet environment if needed.

Nasal congestion or rhinitis (intranasal route)
CommonMild

Transient nasal inflammation or congestion may occur with intranasal VIP. Typically resolves within hours. Use saline rinse if needed; do not use decongestants without consulting your healthcare provider.

Nausea
UncommonMild

Mild nausea may occur, especially at higher doses or on an empty stomach. Manage by taking with food or reducing dose. Resolves within 1-2 hours in most cases.

Dizziness or lightheadedness
UncommonMild

May occur due to vasodilation or rapid absorption. Sit or lie down if this occurs. Ensure adequate hydration and avoid sudden position changes.

Injection site reactions (subcutaneous route)
UncommonMild

Mild erythema, itching, or swelling at the injection site may occur. Rotate injection sites to minimise lipodystrophy. Apply ice if swelling is bothersome.

Hypotension (low blood pressure)
UncommonModerate

VIP is a vasodilator and may lower blood pressure, particularly at higher doses. Monitor blood pressure regularly. Inform your healthcare provider if you are taking antihypertensive medications. Seek medical attention if dizziness or syncope occurs.

Tachycardia (elevated heart rate)
UncommonModerate

Compensatory tachycardia may occur in response to vasodilation. Usually mild and transient. Monitor heart rate; seek medical attention if palpitations or chest discomfort occur.

Allergic reaction
RareSerious

Anaphylaxis or severe allergic reaction is rare but possible. Symptoms include urticaria, angioedema, bronchospasm, or hypotension. Seek immediate emergency medical attention if any signs of anaphylaxis develop. Have an epinephrine auto-injector available if you have a history of peptide allergies.

Immune activation or flare (in CIRS patients)
UncommonModerate

Some CIRS patients report transient worsening of symptoms (cytokine release reaction) in the first 1-2 weeks of VIP therapy, attributed to immune system reactivation. This may include fever, malaise, or exacerbation of existing symptoms. Typically resolves as treatment continues. Inform your healthcare provider if symptoms worsen significantly.

Dosing Reference

ParameterValue
Dose range50 mcg
Frequency, timing and route - members only

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2-8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Molecular weight3357
Half-life1-2 minutes (in circulation; longer in tissue compartments)
SequenceMembers only

VIP (Vasoactive Intestinal Peptide) is a 28-amino acid neuropeptide that acts as a neuroimmune modulator, binding to VPAC1 and VPAC2 G-protein coupled receptors throughout the nervous and immune systems. It exerts anti-inflammatory effects by suppressing pro-inflammatory cytokine production (TNF-α, IL-6, IL-8), promoting regulatory T cell differentiation, and enhancing parasympathetic nervous system signalling. VIP also provides neuroprotection and has been investigated for treatment of chronic inflammatory response syndrome (CIRS) and mast cell activation disorders.

Pathways and mechanism detail available to members

Track your VIP research

Free account. No credit card required.

Start Free

Recent Research

All results

Source: PubMed / NCBI. Updated daily. Articles are listed for research reference only.

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. VIP is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.